124 related articles for article (PubMed ID: 6213743)
1. Scintigraphic evidence for the regression of skeletal metastases from a hypernephroma following long-term treatment with medroxyprogesterone acetate.
Minervini R; Fiorentini L; Carlino F; Mazzuca N; Mariani G
J Nucl Med Allied Sci; 1982; 26(1):55-9. PubMed ID: 6213743
[No Abstract] [Full Text] [Related]
2. Regression of skeletal metastases from hypernephroma following long-term treatment with medroxyprogesterone acetate.
Minervini R; Fiorentini L; Carlino F; Mariani G
J Urol; 1982 Sep; 128(3):605-6. PubMed ID: 6214644
[No Abstract] [Full Text] [Related]
3. Calcification of humeral metastasis of renal adenocarcinoma 8 months after medroxyprogesterone acetate therapy.
Scanni A; Riundi R; Vezzoni MA; Canigiula L
J Urol; 1984 May; 131(5):984. PubMed ID: 6231386
[No Abstract] [Full Text] [Related]
4. Complete regression of skeletal metastases from hypernephroma after angioinfarction and medroxyprogesterone acetate therapy.
Amin R
Urology; 1988 Sep; 32(3):254-8. PubMed ID: 2970709
[No Abstract] [Full Text] [Related]
5. High-dose medroxyprogesterone acetate in patients with renal adenocarcinoma and measurable lung metastases: a phase II study.
Kjaer M; Frederiksen PL
Cancer Treat Rep; 1986 Mar; 70(3):431-2. PubMed ID: 2937534
[No Abstract] [Full Text] [Related]
6. Endocrinological effects of treatment with high doses of medroxyprogesterone acetate in patients with renal or prostatic adenocarcinoma.
Tomic R; Ljungberg B; Damber JE
Scand J Urol Nephrol Suppl; 1988; 110():185-7. PubMed ID: 2973122
[No Abstract] [Full Text] [Related]
7. The role of medroxyprogesterone acetate (MPA) in the treatment of renal adenocarcinoma.
Kjaer M
Cancer Treat Rev; 1988 Sep; 15(3):195-209. PubMed ID: 2974757
[No Abstract] [Full Text] [Related]
8. [A case of disseminated breast cancer successfully treated with medroxyprogesterone acetate].
Tsumura I; Okamura Y; Takatsuka Y; Kobayakawa K; Kawahara T
Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 1):1509-12. PubMed ID: 2143889
[TBL] [Abstract][Full Text] [Related]
9. Treatment of the female metastatic hypernephroma.
Tucker WG
Mich Med; 1973 Aug; 72(24):525-8. PubMed ID: 4726736
[No Abstract] [Full Text] [Related]
10. Advanced adenocarcinoma of the kidney: therapy with lomustine, vinblastine, hydroxyurea, and medroxyprogesterone acetate and regression analysis of factors relating to survival.
Brubaker LH; Troner MB; Birch R
Cancer Treat Rep; 1983; 67(7-8):741-2. PubMed ID: 6223695
[No Abstract] [Full Text] [Related]
11. [Clinovir treatment of adenocarcinoma of the uterus with lung metastases].
Stertmann WA; Hocke M; Röttger P
MMW Munch Med Wochenschr; 1983 Jul; 125(29-30):685-6. PubMed ID: 6225946
[No Abstract] [Full Text] [Related]
12. Nuclear androgen receptor as marker of responsiveness to medroxyprogesterone acetate in human renal cell carcinoma.
Concolino G; Marocchi A; Toscano V; Di Silverio F
J Steroid Biochem; 1981 Dec; 15():397-402. PubMed ID: 6461800
[No Abstract] [Full Text] [Related]
13. [Remarkable pain relief in the treatment with high-dose medroxyprogesterone acetate in advanced prostatic carcinoma].
Sasagawa I; Satomi S; Katayama T
Gan No Rinsho; 1989 May; 35(6):767-71. PubMed ID: 2470932
[TBL] [Abstract][Full Text] [Related]
14. [Experiences with Depo-Provera (medroxyprogesterone) in the treatment of kidney tumors].
Balogh F; Romics I
Z Urol Nephrol; 1987 Aug; 80(8):449-53. PubMed ID: 2961162
[TBL] [Abstract][Full Text] [Related]
15. Hormonal therapy in metastatic hypernephroma.
Peterson LJ; Grimes JH; Dees JE; Anderson EE
Urology; 1974 Dec; 4(6):669-73. PubMed ID: 4454105
[No Abstract] [Full Text] [Related]
16. [The treatment of metastasizing hypernephroid (renal cell) carcinoma with medroxyprogesterone acetate (Clinovir) (author's transl].
von Lieven H; Hahn D
MMW Munch Med Wochenschr; 1977 Aug; 119(34):1089-92. PubMed ID: 408657
[TBL] [Abstract][Full Text] [Related]
17. [Diffuse micrometastatic involvement of the bone marrow: scintigraphic diagnosis with 201Thallium-chloride. Description of a case].
Salvatori M; Saletnich I; Rufini V; Ursitti A; Troncone L
Radiol Med; 1993 Oct; 86(4):527-30. PubMed ID: 8248594
[No Abstract] [Full Text] [Related]
18. Soft tissue extension of bony metastasis identified by bone scanning.
Williamson BR; Bray ST; Teates CD; Lees RF; Croft BY; Cochrane JA
Va Med; 1979 Sep; 106(9):668-9. PubMed ID: 483999
[No Abstract] [Full Text] [Related]
19. [Bone metastases of hypernephroma as the first symptom of the disease].
Malatinský E; Makai F; Jakeś F
Bratisl Lek Listy; 1973; 59(5):601-5. PubMed ID: 4716461
[No Abstract] [Full Text] [Related]
20. Effects of high dose medroxyprogesterone acetate treatment on antithrombin III and other plasma proteins in males with renal cell or prostatic carcinoma.
Nilsson TK; Tomic R; Ljungberg B
Scand J Urol Nephrol; 1989; 23(1):11-4. PubMed ID: 2522237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
